These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27133426)

  • 1. Small molecule tolfenamic acid and dietary spice curcumin treatment enhances antiproliferative effect in pancreatic cancer cells via suppressing Sp1, disrupting NF-kB translocation to nucleus and cell cycle phase distribution.
    Basha R; Connelly SF; Sankpal UT; Nagaraju GP; Patel H; Vishwanatha JK; Shelake S; Tabor-Simecka L; Shoji M; Simecka JW; El-Rayes B
    J Nutr Biochem; 2016 May; 31():77-87. PubMed ID: 27133426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of tolfenamic acid and curcumin induces colon cancer cell growth inhibition through modulating specific transcription factors and reactive oxygen species.
    Sankpal UT; Nagaraju GP; Gottipolu SR; Hurtado M; Jordan CG; Simecka JW; Shoji M; El-Rayes B; Basha R
    Oncotarget; 2016 Jan; 7(3):3186-200. PubMed ID: 26672603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Survivin Inhibitor for Suppressing Pancreatic Cancer Cells Growth via Downregulating Sp1 and Sp3 Transcription Factors.
    Hurtado M; Sankpal UT; Kaba A; Mahammad S; Chhabra J; Brown DT; Gurung RK; Holder AA; Vishwanatha JK; Basha R
    Cell Physiol Biochem; 2018; 51(4):1894-1907. PubMed ID: 30504717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Sp1 and survivin in epithelial ovarian cancer: Sp1 inhibitor and cisplatin, a novel combination for inhibiting epithelial ovarian cancer cell proliferation.
    Sankpal UT; Ingersoll SB; Ahmad S; Holloway RW; Bhat VB; Simecka JW; Daniel L; Kariali E; Vishwanatha JK; Basha R
    Tumour Biol; 2016 Oct; 37(10):14259-14269. PubMed ID: 27581819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolfenamic acid-induced alterations in genes and pathways in pancreatic cancer cells.
    Sankpal UT; Goodison S; Jones-Pauley M; Hurtado M; Zhang F; Basha R
    Oncotarget; 2017 Feb; 8(9):14593-14603. PubMed ID: 28099934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolfenamic acid inhibits neuroblastoma cell proliferation and induces apoptosis: a novel therapeutic agent for neuroblastoma.
    Eslin D; Sankpal UT; Lee C; Sutphin RM; Maliakal P; Currier E; Sholler G; Khan M; Basha R
    Mol Carcinog; 2013 May; 52(5):377-86. PubMed ID: 22213339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer activity of tolfenamic acid in medulloblastoma: a preclinical study.
    Eslin D; Lee C; Sankpal UT; Maliakal P; Sutphin RM; Abraham L; Basha R
    Tumour Biol; 2013 Oct; 34(5):2781-9. PubMed ID: 23686785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of 13 cis-retinoic acid and tolfenamic acid induces apoptosis and effectively inhibits high-risk neuroblastoma cell proliferation.
    Shelake S; Eslin D; Sutphin RM; Sankpal UT; Wadwani A; Kenyon LE; Tabor-Simecka L; Bowman WP; Vishwanatha JK; Basha R
    Int J Dev Neurosci; 2015 Nov; 46():92-9. PubMed ID: 26287661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small molecule tolfenamic acid inhibits PC-3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer.
    Sankpal UT; Abdelrahim M; Connelly SF; Lee CM; Madero-Visbal R; Colon J; Smith J; Safe S; Maliakal P; Basha R
    Prostate; 2012 Nov; 72(15):1648-58. PubMed ID: 22473873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting specificity protein 1 transcription factor and survivin using tolfenamic acid for inhibiting Ewing sarcoma cell growth.
    Shelake S; Sankpal UT; Paul Bowman W; Wise M; Ray A; Basha R
    Invest New Drugs; 2017 Apr; 35(2):158-165. PubMed ID: 28025760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clotam enhances anti-proliferative effect of vincristine in Ewing sarcoma cells.
    Shelake S; Sankpal UT; Eslin D; Bowman WP; Simecka JW; Raut S; Ray A; Basha R
    Apoptosis; 2019 Feb; 24(1-2):21-32. PubMed ID: 30610505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of NFkappaB and pancreatic cancer cell and tumor growth by curcumin is dependent on specificity protein down-regulation.
    Jutooru I; Chadalapaka G; Lei P; Safe S
    J Biol Chem; 2010 Aug; 285(33):25332-44. PubMed ID: 20538607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of clotam and vincristine enhances anti-proliferative effect in medulloblastoma cells.
    Patil S; Sankpal UT; Hurtado M; Bowman WP; Murray J; Borgmann K; Ghorpade A; Sutphin R; Eslin D; Basha R
    Gene; 2019 Jul; 705():67-76. PubMed ID: 30991098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-leukemic response of a NSAID, tolfenamic acid.
    Sutphin RM; Connelly SF; Lee CM; Sankpal UT; Eslin D; Khan M; Pius H; Basha R
    Target Oncol; 2014 Jun; 9(2):135-44. PubMed ID: 23609055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined treatment of pancreatic cancer with mithramycin A and tolfenamic acid promotes Sp1 degradation and synergistic antitumor activity.
    Jia Z; Gao Y; Wang L; Li Q; Zhang J; Le X; Wei D; Yao JC; Chang DZ; Huang S; Xie K
    Cancer Res; 2010 Feb; 70(3):1111-9. PubMed ID: 20086170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular and organismal toxicity of the anti-cancer small molecule, tolfenamic acid: a pre-clinical evaluation.
    Sankpal UT; Lee CM; Connelly SF; Kayaleh O; Eslin D; Sutphin R; Goodison S; Adwan L; Zawia NH; Lichtenberger LM; Basha R
    Cell Physiol Biochem; 2013; 32(3):675-86. PubMed ID: 24030139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin improves the antitumor effect of X-ray irradiation by blocking the NF-κB pathway: an in-vitro study of lymphoma.
    Qiao Q; Jiang Y; Li G
    Anticancer Drugs; 2012 Jul; 23(6):597-605. PubMed ID: 22273827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of curcumin, raspberry extract, and neem leaf extract on rel protein-regulated cell death/radiosensitization in pancreatic cancer cells.
    Veeraraghavan J; Natarajan M; Lagisetty P; Awasthi V; Herman TS; Aravindan N
    Pancreas; 2011 Oct; 40(7):1107-19. PubMed ID: 21697760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Boosting curcumin activity against human prostatic cancer PC3 cells by utilizing scorpion venom conjugated phytosomes as promising functionalized nanovesicles.
    Al-Rabia MW; Alhakamy NA; Rizg WY; Alghaith AF; Ahmed OAA; Fahmy UA
    Drug Deliv; 2022 Dec; 29(1):807-820. PubMed ID: 35266425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expression.
    Konduri S; Colon J; Baker CH; Safe S; Abbruzzese JL; Abudayyeh A; Basha MR; Abdelrahim M
    Mol Cancer Ther; 2009 Mar; 8(3):533-42. PubMed ID: 19258429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.